When should antiretroviral therapy for HIV be started?

Andrew N Phillips; Brian G Gazzard; Nathan Clumeck; Marcelo H Losso; Jens D Lundgren

doi:10.1136/bmj.39064.406389.94

When should antiretroviral therapy for HIV be started?

Andrew N Phillips, Brian G Gazzard, Nathan Clumeck, Marcelo H Losso, Jens D Lundgren

59 Citations (Scopus)

Abstract

Udgivelsesdato: 2007/1/13

Original language	English
Journal	B M J
Volume	334
Issue number	7584
Pages (from-to)	76-78
Number of pages	3
ISSN	0959-8146
DOIs	https://doi.org/10.1136/bmj.39064.406389.94
Publication status	Published - 2007

Keywords

Acquired Immunodeficiency Syndrome
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
HIV Infections
Humans
Risk Factors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmj.39064.406389.94

http://www.bmj.com/cgi/content/full/334/7584/76#bibl

Cite this

@article{4958a5e020ec11ddbc23000ea68e967b,

title = "When should antiretroviral therapy for HIV be started?",

abstract = "Udgivelsesdato: 2007/1/13",

keywords = "Acquired Immunodeficiency Syndrome, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, HIV Infections, Humans, Risk Factors",

author = "Phillips, {Andrew N} and Gazzard, {Brian G} and Nathan Clumeck and Losso, {Marcelo H} and Lundgren, {Jens D}",

year = "2007",

doi = "10.1136/bmj.39064.406389.94",

language = "English",

volume = "334",

pages = "76--78",

journal = "The BMJ",

issn = "0959-8146",